FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject ...
GLP-1 receptor agonists may be superior to aspirin for primary prevention of colorectal cancer, according to study results ...
Benefits of GLP-1 RAs were consistent across age groups and BMI categories, with semaglutide showing significant efficacy. These results were presented during the press briefing ahead of the 2026 ...
Stocktwits on MSN
ASBP stock soars 32% after favorable feedback from FDA for its aspirin – retail expects licensing negotiations soon
Aspire does not expect to conduct additional studies beyond its currently planned multicenter crossover clinical trial. ・The ...
Pharmacogenetics and pharmacogenomics are increasingly recognised as playing a pivotal role in the advancement of personalised medicine, especially in the ...
Findings from a real-world, head-to-head comparison show greater colorectal cancer risk reduction and safety with the use of ...
Early dual antiplatelet therapy shows superior efficacy in reducing stroke recurrence compared with aspirin monotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback